|
HS Code |
273787 |
| Product Name | Boc-Homo-L-Tyrosine |
| Cas Number | 65602-01-1 |
| Molecular Formula | C14H21NO5 |
| Molar Mass | 283.32 g/mol |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Melting Point | 110-114°C |
| Solubility | Slightly soluble in water, soluble in organic solvents like methanol and DMF |
| Storage Conditions | Store at 2-8°C, protect from moisture |
| Functional Group | Boc-protected amino acid |
| Optical Activity | Chiral, usually [α]D value provided upon request |
| Synonyms | N-Boc-4-(2-Aminoethyl)-L-phenol |
As an accredited Boc-Homo-L-Tyrosine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Boc-Homo-L-Tyrosine is supplied in a sealed amber glass vial containing 5 grams, labeled for laboratory use only. |
| Shipping | Boc-Homo-L-Tyrosine is shipped in secure, sealed containers to prevent contamination and ensure product integrity. It is packed with appropriate labeling and documentation, and is transported under ambient conditions unless otherwise specified. Standard handling procedures and regulations for non-hazardous chemicals are followed during shipping to guarantee safety and compliance. |
| Storage | Boc-Homo-L-Tyrosine should be stored in a tightly sealed container, protected from light and moisture. Keep it in a cool, dry, well-ventilated area, ideally at 2–8°C (refrigerated), and away from incompatible substances such as strong oxidizing agents and acids. Proper storage maintains the compound's stability and prevents degradation. Always follow specific manufacturer recommendations and local laboratory safety protocols. |
Applications of Boc-Homo-L-Tyrosine in Industrial ManufacturingBoc-Homo-L-Tyrosine serves as a specialized amino acid derivative essential in multiple advanced synthesis chains. As a direct manufacturer, we supply this raw material to industries with demanding standards for downstream chemical processing, particularly in high-purity pharmaceutical, peptide, and specialty chemical production. The following sections profile core application sectors, outlining compliance, incorporation methods, process stages, and final output forms based on extensive customer feedback and field trials. 1. Peptide API Synthesis for Research and Generic PharmaceuticalsThis raw material plays a critical role as a protected building block in solid phase peptide synthesis (SPPS) and solution phase methods. Leading contract manufacturing organizations and pharmaceutical producers use it for assembling non-standard peptides and modified sequences with enhanced bioavailability or target specificity. The high purity ensures low racemization and compatibility with automated synthesizers across various scales. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Custom Oligopeptide Manufacturing for Diagnostics and AssaysPeptide houses and diagnostic reagent suppliers employ Boc-Homo-L-Tyrosine to extend peptide backbones and introduce altered physicochemical properties. This modification enhances substrate specificity in immunoassays, enzyme-linked detection systems, and customized ligand binding studies. Rigorously controlled lot consistency is mandatory to ensure downstream reproducibility and robustness. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Intermediate for Chiral Pharmaceutical Fine ChemicalsAdvanced fine chemical producers utilize Boc-protected Homo-L-Tyrosine as an optically pure chiral scaffold in the synthesis of non-proteinogenic pharmaceutical intermediates. The selective activation and protection strategy facilitates downstream transformations, including amide coupling, esterification, or cyclization in multistep APIs or advanced key intermediates production targeting CNS and oncology molecules. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Specialty Polymer and Biomaterial SynthesisManufacturers of functional polymers and medical-grade biomaterials use Boc-Homo-L-Tyrosine to introduce pendant aromatic groups, improve hydrophobicity, or adjust mechanical properties in biodegradable copolymers. Its protected structure allows precise delivery within controlled polymerization processes, ensuring functional monomer distribution tailored to application in scaffolding materials, drug delivery matrices, and research-grade hydrogels. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Boc-Homo-L-Tyrosine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Boc-Homo-L-Tyrosine holds a special place in the portfolio of advanced amino acid derivatives. Years of hands-on production have deepened our understanding of its nuances, from early steps in synthesis to large-scale completion. This modified tyrosine, often used in solid-phase peptide synthesis and building novel pharmaceuticals, brings no surprises in its structure: tert-butoxycarbonyl protected on the amino group with an extended side chain. Our facility handles every run of Boc-Homo-L-Tyrosine on dedicated lines, ensuring that each batch gets the same attention to purity and reproducibility.
Nothing replaces close monitoring of every step, starting with strict selection of raw materials. We opt for L-preference feedstocks not only for compliance but because consistency saves downstream troubleshooting. The product’s white crystalline appearance tells only part of the story; fully characterizing it using NMR, HPLC, specific optical rotation, and mass spectrometry offers assurance that each shipment matches published standards. Our spectral libraries track subtle changes in peak patterns over time, allowing us to spot issues early and adjust protocols, particularly when synthesizing directly from hydroxy acids or employing alternate protection strategies.
Demand from leading laboratories and pharma manufacturers centers on two specifications: chemical purity and enantiomeric excess. Boc-Homo-L-Tyrosine needs a purity consistently above 99 percent (HPLC) to satisfy regulatory auditors and to deliver clean peptides without side reactions. Trace chiral impurities—sometimes from racemization or incomplete protection—might cause downstream failures nobody wants to see. By producing this material ourselves, we monitor yields, color, and spectral cues at each stage, so off-spec batches never move forward. Water content also gets checked, since the crystalline product might absorb moisture in storage. We typically pack under inert gas to hold water content below 0.5 percent.
We have learned particular care during crystallization and washing improves storage stability without drifting into over-drying, which helps maintain free-flowing powders. Ample in-process checks ensure final material dissolves rapidly in appropriate solvents used for peptide chemistry. These features may sound mundane, but suppliers learn quickly that even subtle changes can force costly repeats—or worse, ruin an entire sequence after days of labor. Transparency in release testing, with real chromatograms and supporting certificates, creates a working partnership with our customers.
Laboratory projects using Boc-Homo-L-Tyrosine are on the rise, driven by new peptide drugs, modified enzymes, and academic research into unorthodox amino acid sequences. One customer used our product in a recent route toward an anticancer cyclic peptide, counting on it to provide a well-behaved coupling partner with minimal side reactivity or epimerization. For high-throughput applications, reliable batch-to-batch consistency becomes non-negotiable. Variability in protection, purity, or residual solvents can doom a project at the first synthesis step. By controlling the process firsthand, we take real responsibility for delivered quality.
Researchers often ask about subtle structural effects. The homo extension on the tyrosine side chain influences physical and biological behavior, creating opportunities for new targets, increased flexibility, or tuned enzyme resistance in peptides. As manufacturers, we see the tangible results in process yields, resin cleavability, and chromatographic profiles unique to homo analogues. The extended side chain slightly increases hydrophobicity, which sometimes aids separation after synthesis or influences folding in solution. These small differences add up for teams optimizing for performance or simply aiming to push boundaries beyond standard L-tyrosine derivatives.
Over years of production, the distinctions between Boc-Homo-L-Tyrosine and more common derivatives become clear. Boc-L-Tyrosine—without the extra methylene group—remains an established workhorse in peptide synthesis, prized for its reactivity and predictable handling. The ‘homo’ variant introduces subtle changes: higher solubility in some solvents, slight modifications in resin loading procedures, and altered elution profiles during purification. Not every peptide researcher needs these features, but those pioneering new structures or looking to overcome steric challenges find the differences meaningful.
Boc-Homo-L-Tyrosine resists certain oxidative conditions a little better due to backbone modification, potentially increasing shelf life under less-than-ideal storage. Stereochemistry remains just as crucial, as missteps in production lead to mirror-image forms that can disrupt bioactivity. The extended side chain sometimes increases flexibility in resulting peptides, affecting secondary structure or cell permeability studies. By tracking these outcomes in our quality documents, we reinforce long-term trust with partners who care about downstream impacts.
We recognize concerns about safety—in both the lab and production environments. Boc-protected amino acids release tert-butyl cations under acidolysis, so our staff leverages closed handling, local exhaust, and airtight packaging. Each batch ships with recommendations for safe opening and transfer, based on actual experience. We have updated equipment to reduce loss and limit exposure as much as possible with routine internal reviews. Our plant moves toward greener solvents when practical and pairs established methods with solvent recycling to minimize disposal volumes.
Operators who prepare peptide building blocks daily know that reducing exposure isn’t about regulatory minimums—it is about protecting people who operate bench reactors and prepare isolation steps. By holding ourselves to higher standards, we support consistently clean processes. Our goal extends beyond product release: we follow up with lab partners and adapt packaging to fit automatic dispensers or glovebox loading whenever possible.
In chemical production, paperwork often defines trust. We document full analytical data on every production lot of Boc-Homo-L-Tyrosine—no withholding of information or summary-only certificates. Supply chain disruptions have taught that customers want real details: full chromatograms, well-labeled spectra, and ongoing impurity trend tracking across batches. Laboratories and buyers value hands-on assurance that what they order matches reference spectra and historical controls. We stay ready to supply analytical support on request, whether for routine audits or deep-dive investigations during method development.
Long-term project support demands agility. Batch reservation, custom batch sizing, and tailored logistics plans answer evolving research timelines. Our manufacturing schedule juggles kilo-scale lots with custom, smaller runs, which sometimes entails quick changeovers and rush documentation. These extras emerge from regular conversations with lab leads. Sure, day-to-day headaches come with the territory—equipment downtime, last-minute spec modifications, or additional screening. We answer these in stride, knowing that real partnership means more than just selling molecules.
Running production lines for specialty amino acids uncovers real challenges. Boc-Homo-L-Tyrosine sometimes needs minor process tweaks: modulating temperatures during protection steps, calibrating analytical instruments, adjusting the timing on final filtration, and watching for microimpurities that become more visible at scale. Earlier in our operation, a missed water-wash step caused retention of trace byproducts, detected only by a sharp-eyed customer. Improving batch tracking and double-checking new SOPs caught the issue quickly and kept future lot reliability high.
Continuous learning keeps our processes robust. Even established syntheses like Boc-Homo-L-Tyrosine evolve as reagents, techniques, or instrumentation advance. Operator training, regularly reviewed protocols, and cycle reviews after each large run underpin every improvement. We avoid shortcuts: investing in chromatography columns, routine splitting of batches for forensic-style impurity checks, and input from the bench chemists running syntheses. Each improvement helps not only our efficiency but directly benefits every lab downstream.
Pharmaceutical innovators look to Boc-Homo-L-Tyrosine for features not found in standard amino acids. Its precise side-chain extension unlocks new design options in active peptides and bioconjugates. Our feedback loop with customers—academic groups, start-up labs, and industry developers—informs our priorities as a manufacturer. We don’t just sell a bag of powder; we share experience, technical backup, and troubleshooting from years of manufacturing peptides. We notice when the balance of purity and efficient production shifts. By sharing non-confidential best practices, we enable researchers to focus resources on creative work, not fighting avoidable impurities or troubleshooting questionable batches.
Some partners use Boc-Homo-L-Tyrosine to probe bioactivity in antibody mimetics, while others develop new imaging agents incorporating the material’s extended aromatic system. The in-house control over protection, crystallization, and packaging enables us to respond to specialty project needs—be it upscaling or fine-tuning packing for automated synthesisers. We maintain an open inbox for customer feedback and push ourselves to keep information clear, prompt, and actionable.
Market requirements shift as research ambitions grow. The rising popularity of odd chain-length amino acids, non-canonical modifications, and site-specific peptide labeling carries a call for ever-greater confidence in building block quality. We see research proposals that once felt speculative become routine in leading labs around the world. These shifts challenge us to expand our process controls, think about sourcing safer and purer inputs, and stay agile with production timelines that don’t always align with forecasts.
Our team tracks regulatory changes and global chemical stewardship movements—knowing that sustainable manufacturing practices, safer handling, and full compliance all make up the foundation for customer trust. Boc-Homo-L-Tyrosine production serves as a model for how we approach every specialty compound: hands-on, analytical detail from start to finish, and a focus on keeping our partners confident and informed.
Many customers care about timelines, price, and paperwork, but from our viewpoint on the plant floor, it’s all about predictability. Synthesis batches that flow stepwise, clean analytics, and predictable coupling chemistries turn the difference between easy research and missed deadlines. Every bottle we ship reflects the collective experience of operators, analysts, and developmental chemists—trained to spot trends, open to feedback, and ready to adjust. Boc-Homo-L-Tyrosine stands as both a testament to detailed, hands-on production and a reminder that chemical manufacturing remains as much an art as a science, grounded in people, process, and precision.